Filing Details
- Accession Number:
- 0000315066-15-003183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-14 14:40:18
- Reporting Period:
- 2015-10-13
- Filing Date:
- 2015-10-14
- Accepted Time:
- 2015-10-14 14:40:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-10-13 | 2,507,971 | $0.00 | 2,507,971 | No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| Common Stock | Acquisiton | 2015-10-13 | 527,009 | $0.00 | 3,034,980 | No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| Common Stock | Acquisiton | 2015-10-13 | 433,844 | $0.00 | 3,468,824 | No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| Common Stock | Acquisiton | 2015-10-13 | 335,455 | $11.00 | 3,804,279 | No | 4 | P | Indirect | Beacon Bioventures Fund III Limited Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| No | 4 | C | Indirect | Beacon Bioventures Fund III Limited Partnership |
| No | 4 | P | Indirect | Beacon Bioventures Fund III Limited Partnership |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Acquisiton | 2015-10-13 | 8,652,500 | $0.00 | 2,507,971 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Acquisiton | 2015-10-13 | 1,818,182 | $0.00 | 527,009 | $0.00 |
| Common Stock | Series C Convertible Preferred Stock | Acquisiton | 2015-10-13 | 1,496,764 | $0.00 | 433,844 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- On October 13, 2015, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into 0.289855 shares of Common Stock.
Billionaire Hedge Funds
